Edition:
United States

Chiome Bioscience Inc (4583.T)

4583.T on Tokyo Stock Exchange

395JPY
25 Apr 2017
Change (% chg)

-- (--)
Prev Close
¥395
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
336,104
52-wk High
¥935
52-wk Low
¥375

4583.T

Chart for 4583.T

About

Chiome Bioscience Inc. is a company mainly engaged in the research and development of antibody drugs, and the provision of development support services. The Company operates in three business segments. The Drug Discovery Alliance segment is engaged in the research and development of antibodies which aims at the development of... (more)
No analyst recommendations are available for 4583.T.

Overall

Beta: 3.01
Market Cap(Mil.): ¥10,225.68
Shares Outstanding(Mil.): 25.95
Dividend: --
Yield (%): --

Financials

  4583.T Industry Sector
P/E (TTM): -- 58.01 30.10
EPS (TTM): -65.58 -- --
ROI: -32.06 0.27 13.21
ROE: -32.67 6.15 14.37

BRIEF-Chiome Bioscience receives patent in US

* Says it received patent in the U.S. for its product ANTI-HUMAN TROP-2 ANTIBODY HAVING ANTI-TUMOR ACTIVITY IN VIVO

Mar 14 2017

BRIEF-Chiome Bioscience appoints Shigeru Kobayashi as president

* Says it appoints Shigeru Kobayashi as president with effective date on Feb. 14

Feb 14 2017

BRIEF-Chiome Bioscience to raise 6.3 pct stake in Trans Chromosomics Inc.

* Says the co plans to raise stake in Trans Chromosomics Inc. to 6.3 percent from 0 percent

Jan 25 2017

BRIEF-Chiome Bioscience receives patent for METHOD OF INDUCING HOMOLOGOUS RECOMBINATION OF SOMATIC CELL

* Says it received patent grant for METHOD OF INDUCING HOMOLOGOUS RECOMBINATION OF SOMATIC CELL, produced by the co and a Japan-based research institute

Jan 10 2017

More From Around the Web

Earnings vs. Estimates